DURO, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 2.781
NA - Nord America 1.474
EU - Europa 831
SA - Sud America 486
AF - Africa 47
OC - Oceania 7
Totale 5.626
Nazione #
US - Stati Uniti d'America 1.405
SG - Singapore 1.146
CN - Cina 676
BR - Brasile 383
VN - Vietnam 295
IT - Italia 280
HK - Hong Kong 253
FR - Francia 158
NL - Olanda 132
KR - Corea 106
JP - Giappone 64
BD - Bangladesh 62
GB - Regno Unito 59
DE - Germania 56
IN - India 47
FI - Finlandia 37
AR - Argentina 34
CA - Canada 32
MX - Messico 20
EC - Ecuador 19
ID - Indonesia 18
IQ - Iraq 17
PL - Polonia 17
TR - Turchia 16
ES - Italia 13
IL - Israele 13
ZA - Sudafrica 13
CL - Cile 12
EG - Egitto 10
RU - Federazione Russa 10
CO - Colombia 8
SA - Arabia Saudita 8
SE - Svezia 8
UA - Ucraina 8
AU - Australia 7
PK - Pakistan 7
PY - Paraguay 7
VE - Venezuela 7
DZ - Algeria 6
LT - Lituania 6
MA - Marocco 6
PE - Perù 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
BO - Bolivia 5
PH - Filippine 5
AZ - Azerbaigian 4
BE - Belgio 4
CZ - Repubblica Ceca 4
GR - Grecia 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
BG - Bulgaria 3
GT - Guatemala 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IE - Irlanda 2
LV - Lettonia 2
PT - Portogallo 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LS - Lesotho 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
Totale 5.622
Città #
Singapore 689
Santa Clara 482
Hefei 247
Hong Kong 246
San Jose 208
Lauterbourg 128
Beijing 118
Ashburn 116
Seoul 101
Ho Chi Minh City 99
Los Angeles 76
Hanoi 73
Tokyo 49
Dallas 44
São Paulo 27
Guangzhou 25
Frankfurt am Main 24
New York 22
Orem 21
Buffalo 20
Helsinki 19
Lappeenranta 17
Milan 16
Rome 16
Council Bluffs 15
Da Nang 15
Naples 15
London 13
Rio de Janeiro 13
Curitiba 12
Minamishinagawa 12
Palermo 12
Brasília 11
Düsseldorf 11
Haiphong 11
Montreal 11
Ninh Bình 11
Warsaw 11
Bengaluru 9
Campinas 9
Chennai 9
Elk Grove Village 9
Florence 9
Hyderabad 9
Cairo 8
Mexico City 8
Stockholm 8
Atlanta 7
Charlotte 7
Houston 7
Amsterdam 6
Ankara 6
Baghdad 6
Bari 6
Guayaquil 6
Munich 6
Padua 6
Phoenix 6
Quito 6
Salvador 6
Tashkent 6
Toronto 6
Belo Horizonte 5
Biên Hòa 5
Blumenau 5
Brooklyn 5
Buenos Aires 5
Johannesburg 5
Porto Alegre 5
Portsmouth 5
Redondo Beach 5
Ribeirão Preto 5
Thái Bình 5
Vũng Tàu 5
Aparecida de Goiânia 4
Baku 4
Boston 4
Bắc Ninh 4
Dhaka 4
Erbil 4
Falkenstein 4
Hải Dương 4
Lima 4
Madrid 4
Messina 4
Newark 4
Nuremberg 4
Paris 4
Riyadh 4
San Francisco 4
Santiago 4
Santo André 4
Sydney 4
São Bernardo do Campo 4
Thái Nguyên 4
Venice 4
Vienna 4
Wroclaw 4
Amman 3
Bangkok 3
Totale 3.389
Nome #
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 104
Expanded screening for Fabry disease in patients with chronic kidney disease not on dialysis: a multicenter Italian experience 102
miR-126-3p and miR-21-5p as Hallmarks of Bio-Positive Ageing; Correlation Analysis and Machine Learning Prediction in Young to Ultra-Centenarian Sicilian Population 102
Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women 99
Highlights of Precision Medicine, Genetics, Epigenetics and Artificial Intelligence in Pompe Disease 92
Molecular and clinical studies in five index cases with novel mutations in the GLA gene. 81
Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease 79
Diagnosis of Fabry Disease Using Alpha-Galactosidase A Activity or LysoGb3 in Blood Fails to Identify Up to Two Thirds of Female Patients 78
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? 77
Early Cardiac involvement affects left ventricular longitudinal function in females carrying ?- galactosidase a mutation role of hybrid positron emission tomography and magnetic resonance imaging and speckle-tracking echocardiography 74
Pompe disease: pathogenesis, molecular genetics and diagnosis 73
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance 69
A novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 68
Hemochromatosis Mimicked Gaucher Disease: Role of Hyperferritinemia in Evaluation of a Clinical Case 68
Transforming Growth Factor 1 T29c Gene Polymorphism And Hypertension: Relationship With Cardiovascular And Renal Damage 67
Polymorphisms in the intergenic region of the sea urchin Paracentrotus lividus ribosomal DNA 66
Calnexin is down-regulated in Fabry disease. A possible implication in protein misfolding 66
The Identification of a Novel Pathogenic Variant of the GLA Gene Associated with a Classic Phenotype of Anderson–Fabry Disease: A Clinical and Molecular Study 66
Late-Onset Pompe Disease with Normal Creatine Kinase Levels: The Importance of Rheumatological Suspicion 66
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 66
Fabry Disease and Inflammation: Potential Role of p65 iso5, an Isoform of the NF-κB Complex 65
Mutation Spectrum of GAA Gene in Pompe Disease: Current Knowledge and Results of an Italian Study 63
Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis 62
Translation of Basic Research into Clinics: Killer Immunoglobulin-like Receptors Genes in Autoimmune and Infectious Diseases 61
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area 61
Simple and inexpensive dot-blot apparatus 59
Myocardial dysfunction in Anderson-Fabry disease (AFD) without ventricular hypertrophy 59
Up-regulation of gamma-enolase in PMC from Fabry patients 57
Identification of Novel Mutations in Patients Affected by Gaucher Disease 57
De novo mutation in a male patient with Fabry disease: a case report 57
European Biotech week 53
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease 53
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 53
HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus 52
Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings. 52
Misdiagnosi di Febbre Mediterranea Familiare in pazienti con Malattia di Anderson-Fabry 52
Newborn screening for fabry disease in northeastern italy: Results of five years of experience 51
Fabry disease, a complex pathology not easy to diagnose 51
Blood group does not appear to affect longevity a pilot study in centenarians from Western Sicily. 50
A new p65 isoform that bind the glucocorticoid hormone and is expressed in inflammation liver diseases and COVID-19 50
Age-related inflammation: the contribution of different organs, tissues and systems. how to face it for therapeutic approaches. 48
Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings 48
Case report: De novo mutation of a-galactosidase A in a female patient with end-stage renal disease: report of a case of late diagnosis of Anderson–Fabry disease 47
Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signs. 43
Circulating miRNAs in Successful and Unsuccessful Aging. A Mini-review 43
High variability of fabry disease manifestations in an extended italian family 42
A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report 42
Analysis of mutations in the GLA and MEFV genes might determines a genetic variant of Fabry diseases 42
Fabry disease: a proteomic approach 42
Novel alpha-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease 40
Proteomic approach in Fabry disease: a case report 40
Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy. 40
Identification of cross-reactive and genuine Parietaria judaica pollen allergens 40
DNA methylation impact on Fabry disease 40
Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease 39
Fabry Disease Beyond Storage: The Role of Inflammation in Disease Progression 39
Novel alpha-galactosidase A mutation in a female with recurrent strokes. 39
Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease 38
GM Allotypes and COVID-19. A Pilot Study Performed on Sicilian Patients. 38
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection 37
Genetic screening of Fabry patients with EcoTILLING and HRM technology 37
Alterazioni introniche in soggetti con sintomatologia riconducibile alla malattia di Fabry 37
Immune-inflammatory responses and oxidative stress in Alzheimer' disease: therapeutic implications 36
HLA and Killer Cell Immunoglobulin-like Receptors Influence the Natural Course of CMV Infection. 35
Assignment of disulphide bridges in Parj 2.0101, a major allergen of Parietaria judaica pollen 35
Mucopolysaccharidosis Type I and α-Mannosidosis—Phenotypically Comparable but Genetically Different: Diagnostic and Therapeutic Considerations 35
Distribution of KIR Genes and Their HLA Ligands in Different Viral Infectious Diseases: Frequency Study in Sicilian Population 35
Parietaria judaica ns-LTP antigen variants, uses thereof and compositions comprising them 35
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 34
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease 34
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation? 34
How Important Are Genes to Achieve Longevity? 34
Hypoallergenic fragment of Par j 2 increases functional expression of Toll-like receptors in atopic children 33
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 33
Multiplex Ligation Probe Amplification and Sanger Sequencing: Light and Shade in the Diagnosis of Lysosomal Storage Disorders 33
Healthy ageing and Mediterranean diet: A focus on hormetic phytochemicals 33
Ambiente e Salute: dal monitoraggio aerobiologico alla prevenzione 32
An update on allergens. Parietaria pollen allergens. 32
Use of a pure allergen component 32
Parietaria pollen allergens: a model to study the Type I allergy 31
Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: A comparative study 31
VEXAS Syndrome: Genetics, Gender Differences, Clinical Insights, Diagnostic Pitfalls, and Emerging Therapies 30
Peptidi derivati dall'allergene par j 2 del polline di parietaria judaica 30
Varianti di allergeni NS-LTPS, loro usi e composti che le comprendono 30
Germline mosaicism for the c.2021G>A (p.Arg674Gln) mutation in siblings with trismus pseudocamptodactyly. 29
IDENTIFICATION OF AN IMMUNODOMINANT IGE EPITOPE OF THE PARIETARIA JUDAICA MAJOR ALLERGEN. 29
A method for eluting DNA in a wide range of molecular weights from agarose gels 29
Readthrough transcription occurs at the rho dependent signal F1 TIV in suppressor cells 28
Response to Simsek et al. 28
Intragenomic recombination between homologous regions of genes II and IV promotes formation of bacteriophage f1 miniphages 27
The signature of longevity in Sicily 27
Isolation of proteins and nucleic acids by electrophoresis on disposable gel columns 27
Genotypic and phenotypic aspects of longevity: Results from a sicilian survey and implication for the prevention and treatment of age-related diseases 27
cDNA cloning, sequence analysis and allergological characterization of Par j 2.0101, a new major allergen of the Parietaria judaica pollen 27
Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy 27
Identification of an Immunodominant IgE Epitope of the Parietaria judaica Major Allergen 27
Hypoallergenic fragment of Parj2 increases functional expression of toll like receptors in atopic children 26
Method for eluting DNA from agarose gels 26
In vivo and in vitro effects of variants of Parj2 in asthmatic children. 26
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema. 26
Totale 4.745
Categoria #
all - tutte 18.690
article - articoli 16.329
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 96
Totale 35.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202436 0 0 0 0 0 0 0 0 4 0 26 6
2024/20252.237 79 11 160 74 467 71 12 128 114 147 524 450
2025/20263.490 173 288 332 542 658 132 480 172 206 283 224 0
Totale 5.763